Elanco Animal Health
ELAN
371 hedge funds and large institutions have $8.52B invested in Elanco Animal Health in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 125 increasing their positions, 123 reducing their positions, and 65 closing their positions.
120% more call options, than puts
Call options by funds: $40.2M | Put options by funds: $18.3M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 65
2% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 123
0% more funds holding
Funds holding: 371 → 371 (0)
2.01% less ownership
Funds ownership: 101.45% → 99.44% (-2%)
6% less capital invested
Capital invested by funds: $9.05B → $8.52B (-$536M)
Top Buyers
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
+$290M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$234M |
| 3 |
BlackRock
New York
|
+$99.2M |
| 4 |
JP Morgan Chase
New York
|
+$70.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$58.4M |
Top Sellers
ELAN Hedge Fund Activity: Q2 2020 in Review
371 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2020, worth a combined $8.52B — down 5.9% from $9.05B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new ELAN positions and 65 closed out — a net gain of 3 holders — while 125 added to existing stakes and 123 trimmed.
The largest buyer was Aristotle Capital Management, adding an estimated $290M. The largest seller was Invesco, cutting an estimated $186M.
- 371 institutional investors held Elanco Animal Health (ELAN) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $8.52B of Elanco Animal Health stock for Q2 2020, down 5.9% quarter-over-quarter.
- 68 funds opened new Elanco Animal Health positions in Q2 2020 and 65 closed out, a net change of +3 holders.
- The largest Elanco Animal Health buyer in Q2 2020 was Aristotle Capital Management, an estimated $290M added.
- The largest Elanco Animal Health seller in Q2 2020 was Invesco, an estimated $186M sold.
Based on aggregated 13F filings for Q2 2020.